Skip to main content
Omada Health10-K: Market expansion

Expanding platform to cover multiple chronic conditions including MSK, Hypertension, and Diabetes.

What happened

Omada is executing a multi-condition platform strategy, expanding beyond its original diabetes prevention program to address musculoskeletal (MSK), hypertension, and diabetes management.

Source

SEC EDGARMar 6, 2026

Annual report (Form 10-K)

Omada Health 10-K for FY2025

Filing excerpt

Since then, we also observed a demand from our customers and channel partners to expand beyond diabetes prevention and weight management and into other conditions, such as the treatment and management of diabetes, hypertension, and high cholesterol as well as supporting members on their glucagon-like peptide-1 agonists (“GLP-1”) weight-loss journeys.

sec.gov/Archives/edgar/data/1611115/000162828026015637/omda-20251231.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-K: Market expansion

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/31
Filed
Mar 6, 2026

More 10-K signals at other companies

The full record

From the Signal API record

Details

CIK
1611115
Accession number
0001628280-26-015637
Timeframe
Current year
Filing year
2026
Why it matters
Scaling infrastructure needed

Topics and mentions

Vendors

  • Physera Physical Therapy Group
  • PC

Vendors named

  • Physera Physical Therapy Group, PC

Extraction

Confidence
High
Relevance
70%
Sentiment
Positive
Detected
Mar 10, 2026
signal_type
sec-10k
signal_subtype
marketExpansion

Use this data

Get every 10-K signal for Omada Health and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Omada Health this week?”

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/665ace9f-cf2b-46d7-96cc-41a89f36ea0d returns this record as JSON. POST /v1/companies/enrich returns every signal for omadahealth.com.

{
  "signal_id": "665ace9f-cf2b-46d7-96cc-41a89f36ea0d",
  "signal_type": "sec-10k",
  "signal_subtype": "marketExpansion",
  "detected_at": "2026-03-10T06:52:52.225+00:00",
  "company": {
    "name": "Omada Health",
    "domain": "omadahealth.com"
  },
  "data": {
    "detail": "Omada is executing a multi-condition platform strategy, expanding beyond its original diabetes prevention program to address musculoskeletal (MSK), hypertension, and diabetes management. This diversification increases their total addressable market and cross-selling opportunities but also creates complexity in care delivery and technology integration.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "Expanding platform to cover multiple chronic conditions including MSK, Hypertension, and Diabetes.",
    "excerpts": "Since then, we also observed a demand from our customers and channel partners to expand beyond diabetes prevention and weight management and into other conditions, such as the treatment and management of diabetes, hypertension, and high cholesterol as well as supporting members on their glucagon-like peptide-1 agonists (“GLP-1”) weight-loss journeys.",
    "relevance": 0.7,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1611115/000162828026015637/omda-20251231.htm",
    "filing_date": "2026-03-06",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Scaling infrastructure needed",
    "signal_category": "market",
    "vendors_mentioned": [
      "Physera Physical Therapy Group, PC"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.